The Effect of 4 Weeks Aerobic Exercise Training with Detraining Courses in Various Prevention Phases on BCl‑2 and BAX Genes Expression and Proteins

Yousef Shahvali Koohshoori, Sayed M. Marandi, Mehdi Kargarfard, Golnaz Vaseghi, Seyed J. Moshtaghian

Abstract


Background: The aim of this study was to investigate the effect of aerobic exercise with detraining in different phases of prevention on BCL2 Associated X (BAX) and B-cell lymphoma 2 (BCl‑2) gene expression and proteins. Methods: For this purpose, 32 female Balb‑c mice (18–20 g) were purchased and randomly assigned to primordial prevention (A), primary prevention (B), secondary prevention (C), and control (D). A group performed aerobic exercise for 4 weeks, after 4T1 cells injection detrained for 8 weeks. Group B performed aerobic exercise for 4 weeks immediately after injecting 4T1 cells and then detrained for 4 weeks. In C group, the 4T1 cells were first injected and did not perform any activity for 4 weeks, followed by 4 weeks of aerobic exercise. Forty‑eight hours after the last training session and detraining courses, after anesthesia, sacrificing, and tissue removal, were performed. Reverse transcription polymerase chain reaction (RT PCR) was used to measure gene expression and Western blot (WB) was used to measure protein content. One‑way Analysis of variance (ANOVA) test was used to analyze data. Results: The results showed that aerobic exercise in A, B, and C groups compared to D group reduced BCl‑2 gene expression and protein and increased BAX gene expression and protein. Conclusions: Therefore, exercise can cause apoptosis in tumor cells by increasing pre‑apoptotic factors and decreasing antiapoptotic factors in tumor cells, and consequently improving the disease status.

Keywords


Aerobic exercise; apoptosis; detraining; primary prevention; primordial prevention; secondary prevention

Full Text:

PDF

References


Poorkiani M, Hazrati M, Abbaszadeh A, Jafari P, Sadeghi M,

Dejbakhsh T, et al. Does arehabilitation program improve quality

of life in breast cancer patients. Payesh 2010;9:61‑8.

Aghabarari M, Ahamadi F, Mohammadi E, Hajizadeh E,

Farahania V. Physical, emotional and social dimension of quality

of life among breast cancer women under chemotherapy. Iran J

Nurs Res 2005;3:55‑65.

Nafissi N, Saghafinia M, Motamedi MH, Akbari ME. A survey

of breast cancer knowledge and attitude in Iranian women.

J Cancer Res Ther 2012;8:46‑9.

Banegas MP, Bird Y, Moraros J, King S, Prapsiri S, Thompson B.

Breast cancer knowledge, attitudes, and early detection

practices in United States‑Mexico border Latinas. J Womens

Health (Larchmt) 2012;21:101‑7.

Harirchi I, Kolahdoozan S, Karbakhsh M, Chegini N,

Mohseni SM, Montazeri A, et al. Twenty years of breast cancer

in Iran: Downstaging without a formal screening program. Ann

Oncol 2011;22:93‑7.

Hashemian M, Ghardashi F, Asadi Z, Khosroabadi AA, Pejhan A,

Javan R, et al. Incidence and screening of breast cancer in

Iranian women. Life Sci J 2013;10:361‑6.

Rezagholi T, Yavari P, Abolhasani F, Etemad K, Khosravi A,

Hashemi‑Nazari SS, et al. [Estimating the burden of

breast cancer in Iranian women in 2009]. Iran J Epidemiol

;10:32‑40. (Persian).

Khazaee‑pool M, Majlessi F, Foroushani AR, Montazeri A,

Nedjat S, Shojaeizadeh D, et al. Perception of breast cancer

screening among Iranian women without experience of

mammography: A qualitative study. Asian Pac J Cancer Prev

;15:3965‑71.

Vainio H, Bianchini F; International Agency for Research on

Cancer Working Group on the Evaluation of Cancer‑Preventive

Agents. Weight Control and Physical Activity. Lyon, France:

International Agency for Research on Cancer; 2002.

Xue F, Michels KB. Diabetes, metabolic syndrome, and breast

cancer: A review of the current evidence. Am J Clin Nutr

;86:823S‑35S.

Hoffman LG, Wahnefried WD, Goran MI, McTiernan A,

Reichman ME. Possible mechanism mediating an association

between physical activity and breast cancer. Presented at the

national action plan on breast cancer workshop on physical

activity and breast cancer, Albuquerque, New Mexico, 1997.

Nieman DC, Nehlsen‑Cannarella SI, Henson DA,

Butterworth DE, Fagoaga OR, Warren BJ, et al. Immune

response to obesity and moderate weight loss. Int J Obes Relat

Metab Disord 1996;20:353‑60.

Wong RSY. Apoptosis in cancer: From pathogenesis to treatment.

J Exp Clin Cancer Res 2011;30:87.

Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane

permeabilization in cell death. Physiol Rev 2007;87:99‑163.

Campbell KL, McTiernan A, Li SS, Sorensen BE, Yasui Y,

Lampe JW, et al. Effect of a 12‑month exercise intervention on

the apoptotic regulating proteins bax and Bcl‑2 in colon crypts:

A randomized controlled trial. Cancer Epidemiol Biomarkers

Prev 2007;16:1767‑74.

Foo JB, Yazan LS, Tor YS, Wibowo A, Ismail N, How CW,

et al. Induction of cell cycle arrest and apoptosis by betulinic

acid‑rich fraction from Dillenia suffruticosa root in MCF‑7

cells involved p53/p21 and mitochondrial signalling pathway.

J Ethnopharmacol 2015;166:270‑8.

Aruoma OI, Bahorun T, Agnihotri AK. Cancer risks and

perspectives: Molecular mechanisms. Mutat Res 2014;768:1‑5.

McIlwain DR, Berger T, Mak TW. Caspase functions in cell death

and disease. Cold Spring Harb Perspect Biol 2013;5:a008656.

Cory S, Adams JM. The BcL2 family: Regulators of the cellular

life‑or‑death switch. Nat Rev Cancer 2002;2:647‑56.

Kim R, Emi M, Tanabe K, Toge T. Therapeutic potential of

antisense Bcl-2 as a chemosensitizer for cancer therapy. Cancer

;101:2491‑502.

Friedenreich CM, Cust AE. Physical activity and breast cancer

risk: Impact of timing, type and dose of activity and population

subgroup effects. Br J Sports Med 2008;42:636‑47.

Eliassen AH, Hankinson SE, Rosner B, Holmes MD, Willett WC.

Physical activity and risk of breast cancer among postmenopausal

women. Arch Intern Med 2010;170:1758‑64.

Moodi M, Sharifirad GR, Tahergorabi Z, Mostafavi F. Get to

Know Breast Cancer Pathway toward Health. 1st ed. Isfahan

University of Medical Sciences Publisher; 2012. [Persian].

O’Connell S, Asnltzr B, Sami P. Disease in Women and Breast

and Genitals ‑ Urinary Male. Tehran: Tohfeh; 2004. p. 144.

Jones LW, Viglianti BL, Tashjian JA, Kothadia SM, Keir ST,

Freedland SJ, et al. Effect of aerobic exercise on tumor

physiology in an animal model of human breast cancer. J Appl

Physiol (1985) 2010;108:343‑8.

de Lima C, Alves L, Iagher F, Machado AF, Kryczyk M,

Yamazaki RK, et al. Tumor growth reduction in Walker 256

tumor‑bearing rats performing anaerobic exercise: Participation

of Bcl‑2, Bax, apoptosis, and peroxidation. Appl Physiol Nutr

Metab 2011;36:533‑8.

Khori V, Amani Shalamzari S, Isanejad A, Alizadeh AM,

Alizadeh S, Khodayari S, et al. Effects of exercise training

together with tamoxifen in reducing mammary tumor burden in

mice: Possible underlying pathway of miR‑21. Eur J Pharmacol

;765:179‑87.

Rafiei MM, Gaeini AA, Kordi MR, Nuri R. The effect of eight weeks of aerobic exercise on gene expression of cytochrome C,

Caspase 9 and tumor volume in mice with breast cancer. Rep

Health Care 2018;4:55‑60.

Alizadeh AM, Heydari Z, Rahimi M, Bazgir B, Shirvani H,

Alipour S, et al. Oxytocin mediates the beneficial effects of the

exercise training on breast cancer. Exp Physiol 2018;103:222‑35.

Garcia‑Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R,

Royue M. IL‑6, its receptors and its relationship with Bcl‑2 and

Bax proteins in infiltrating and in situ human breast carcinoma.

Histopathology 2005;47:82‑9.

Shalamzari SA, Agha‑Alinejad H, Alizadeh S, Shahbazi S,

Khatib ZK, Kazemi A, et al. The effect of exercise training

on the level of tissue IL‑6 and vascular endothelial growth

factor in breast cancer bearing mice. Iran J Basic Med Sci

;17:231‑58.

Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M,

Lock RB. Bcl‑2 inhibits Bax translocation from cytosol to

mitochondria during drug‑induced apoptosis of human tumor

cells. Cell Death Differ 2000;7:102‑11.

Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, et al.

Knockdown of miR‑21 in human breast cancer cell lines inhibits

proliferation, in vitro migration and in vivo tumor growth. Breast

Cancer Res 2011;13:R2.

Isomoto H, Kobayashi S, Werneburg NW, Bronk SF,

Guicciardi ME, Frank DA, et al. Interleukin 6 upregulates

myeloid cell leukemia-1 expression through a STAT3 pathway in

cholangiocarcinoma cells. Hepatology 2005;42:1329‑38.

Wang GL, Jiang B‑H, Rue EA, Semenza GL. Hypoxia‑inducible

factor 1 is a basic‑helix‑loop‑helix‑PAS heterodimer regulated by

cellular O2 tension. Proc Natl Acad Sci U S A 1995;92:5510‑4.

Coyle YM. Physical activity as a negative modulator of

estrogen‑induced breast cancer. Cancer Causes Control

;19:1021‑9.

Maryam N, Ayoub B, Mohamadreza B, Mahdi GB. The

effect of six weeks of resistance training on tumor tissue

VEGF and endostatin in mice with breast cancer. Sport Biosci

;5:27‑46. (in Persian).

Agha‑Alinejad H, Hashemi Jokar E. Effect of six weeks of

interval exercise training along with selenium nanoparticle

ingestion on Bcl‑2 and LC3 genes expression in the tumor tissue

of breast tumor‑bearing mice. Iran Q J Breast Dis 2019;12:26‑37.

Fei Z, Li D, Li K, Zhou M, Li Y, Li Y, et al. Detraining after

tumor‑bearing accelerates tumor growth while continuous training

decreases tumor growth in mice. J Tradit Chin Med Sci 2020;7:75‑81.